Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Imjudo | tremelimumab-actl | AstraZeneca | N-761289 RX | 2022-10-21 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
imjudo | Biologic Licensing Application | 2024-07-24 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hepatocellular carcinoma | — | D006528 | C22.0 |
Expiration | Code | ||
---|---|---|---|
tremelimumab, Imjudo, AstraZeneca AB | |||
2029-10-21 | Orphan excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 12 | 18 | 7 | — | 3 | 34 |
Non-small-cell lung carcinoma | D002289 | — | — | 4 | 9 | 6 | — | 2 | 21 |
Neoplasms | D009369 | — | C80 | 9 | 10 | 1 | — | — | 18 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 2 | 8 | 4 | — | 4 | 17 |
Lung neoplasms | D008175 | — | C34.90 | 4 | 7 | 5 | — | — | 16 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 6 | 4 | — | 2 | 13 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 7 | 8 | 2 | — | — | 12 |
Squamous cell carcinoma | D002294 | — | — | 7 | 8 | 1 | — | — | 11 |
Urinary bladder neoplasms | D001749 | — | C67 | 2 | 8 | 1 | — | — | 10 |
Small cell lung carcinoma | D055752 | — | — | 4 | 3 | 3 | — | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | 2 | 8 | — | — | — | 8 |
Colorectal neoplasms | D015179 | — | — | 4 | 6 | — | — | — | 8 |
Recurrence | D012008 | — | — | 2 | 5 | — | — | — | 6 |
Biliary tract neoplasms | D001661 | — | C24.9 | 2 | 4 | — | — | — | 6 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 4 | 2 | — | — | — | 6 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 4 | — | — | — | 6 |
Cholangiocarcinoma | D018281 | — | C22.1 | — | 4 | — | — | — | 4 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | 3 | — | — | — | 4 |
Prostatic neoplasms | D011471 | — | C61 | 2 | 4 | — | — | — | 4 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 2 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | — | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | — | — | — | — | 1 |
Vaginal neoplasms | D014625 | — | C52 | 1 | — | — | — | — | 1 |
Vulvar neoplasms | D014846 | — | C51 | 1 | — | — | — | — | 1 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
Anaplastic thyroid carcinoma | D065646 | — | — | 1 | — | — | — | — | 1 |
Thyroid diseases | D013959 | — | E00-E07 | 1 | — | — | — | — | 1 |
Esophageal squamous cell carcinoma | D000077277 | — | — | 1 | — | — | — | — | 1 |
Pharyngeal neoplasms | D010610 | — | C14.0 | 1 | — | — | — | — | 1 |
Peritoneal neoplasms | D010534 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Tremelimumab |
INN | tremelimumab |
Description | Tremelimumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >5GGV:H|heavy chain
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLY
LQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPE
PVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTHHHHHH
>5GGV:L|light chain
DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQP
EDFATYYCQQYYSTPFTFGPGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5GGU, 5GGV |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108658 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB11771 |
UNII ID | QEN1X95CIX (ChemIDplus, GSRS) |